Last update 28 Feb 2026

RGD-MMAE−HSA

Overview

Basic Info

Drug Type
Protein drug conjugate
Synonyms-
Target
Tubulin x αvβ3
Action
inhibitors, antagonists
Mechanism
Tubulin inhibitors, αvβ3 antagonists(Integrin alpha-V/beta-3 antagonists)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
Seagen, Inc.Seagen, Inc.University of GroningenUniversity of GroningenKreatech Biotechnology BVKreatech Biotechnology BV
Active Organization-
Inactive Organization
Kreatech Biotechnology BVKreatech Biotechnology BVUniversity of GroningenUniversity of GroningenSeagen, Inc.Seagen, Inc.
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC39H67N5O7
InChIKeyDASWEROEPLKSEI-UIJRFTGLSA-N
CAS Registry474645-27-7
Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

100 Clinical Results associated with RGD-MMAE−HSA
Login to view more data
100 Translational Medicine associated with RGD-MMAE−HSA
Login to view more data
100 Patents (Medical) associated with RGD-MMAE−HSA
Login to view more data
100 Deals associated with RGD-MMAE−HSA
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
United States
Seagen, Inc.Seagen, Inc.
17 Oct 2006
NeoplasmsPreclinical
Netherlands
University of GroningenUniversity of Groningen
17 Oct 2006
NeoplasmsPreclinical
Netherlands
Kreatech Biotechnology BVKreatech Biotechnology BV
17 Oct 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free